GlassScriptPhysician profile
Reza Masoomi
NPI 1902244056
$9,987.22
in general payments reported to CMS, 2019-2025
45 companies · $1,120 in 2025
The $1,120 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,824 · 2020: $1,553 · 2021: $1,173 · 2022: $1,516 · 2023: $1,653 · 2024: $1,148 · 2025: $1,120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,725 · Travel and Lodging: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,725.20 |
| Travel and Lodging | $194.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,021.05 | 2019-2024 | Pressurewire, Diamondback Coronary |
| Boston Scientific Corporation | $1,001.86 | 2019-2025 | General - Vascular Access |
| Abiomed | $746.19 | 2019-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $733.43 | 2020-2024 | |
| Chiesi USA, INC. | $610.89 | 2019-2024 | Kengreal |
| Astrazeneca Pharmaceuticals LP | $608.26 | 2019-2025 | Farxiga |
| Shockwave Medical, INC | $558.43 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $477.05 | 2019-2023 | Lifevest |
| Edwards Lifesciences Corporation | $392.61 | 2024-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Cardiovascular Systems INC. | $372.24 | 2019-2020 | |
| Cardiva Medical, INC. | $279.37 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $220.55 | 2019-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $197.19 | 2019-2022 | |
| Verge Medical, INC. | $194.01 | 2023 | |
| Philips North America LLC | $187.05 | 2019-2022 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $185.91 | 2022-2023 | Verquvo |
| Nuwellis, INC. | $170.04 | 2022 | |
| Terumo Medical Corporation | $169.77 | 2019-2020 | |
| Amgen INC. | $158.29 | 2022-2023 | Repatha |
| Impulse Dynamics (USA) INC. | $156.90 | 2022 | |
| Asahi Intecc USA, INC. | $153.99 | 2023-2024 | Peripheral Vascular, Asahi Ptca Guide Wire |
| Medtronic, INC. | $132.37 | 2021-2025 | Ffrangio, Endurant Iis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $129.88 | 2021-2023 | Jardiance |
| Biotronik INC. | $118.12 | 2023 | |
| Cook Medical LLC | $104.20 | 2019-2023 | Advance, Tornado |
| Cardinal Health 200 LLC | $91.80 | 2019 | |
| Novo Nordisk INC | $87.54 | 2021-2022 | |
| Heartflow, INC. | $79.87 | 2023 | Ffrct |
| Kiniksa Pharmaceuticals, LTD. | $73.24 | 2021-2023 | Arcalyst |
| Teleflex LLC | $73.03 | 2024 | Turnpike |
| Angiodynamics, INC. | $60.92 | 2022 | |
| Reflow Medical INC | $59.56 | 2024 | |
| Pfizer INC. | $52.47 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $43.46 | 2023 | |
| Amarin Pharma, INC. | $42.80 | 2020-2021 | |
| W. L. Gore & Associates, INC. | $42.42 | 2020 | |
| Acacia Pharma INC | $36.22 | 2021-2022 | |
| Merit Medical Systems INC | $32.89 | 2020 | |
| Penumbra, INC. | $22.28 | 2020 | |
| Esperion Therapeutics, INC. | $19.76 | 2020 | |
| Surmodics, INC. | $19.33 | 2022 | |
| Cordis US Corp. | $18.81 | 2025 | Mynx Control |
| Astellas Pharma US INC | $18.76 | 2021 | |
| Medtronic Vascular, INC. | $18.11 | 2019 | |
| Cmp Pharma, INC. | $14.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reza Masoomi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.